N/A
N=1,245
Tobacco Intervention in Primary Care Treatment Opportunities for Providers
Smoking · Smoking Cessation
Bottom Line
View on ClinicalTrials.gov: NCT02096029 ↗Enrolled (actual)
1,245
Serious AEs
2.3%
Results posted
Aug 2019
Primary outcome: Primary: Percentage of Participants With 7-Day Self-Reported Point Prevalence Abstinence — 12; 8 percentage of participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Nicotine Replacement Therapy (NRT) Sampling (Other); Ask, Advise, Refer (physician brief advice) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- Jun 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With 7-Day Self-Reported Point Prevalence Abstinence |
12; 8 | — |
| SECONDARY Any Self-defined Attempt to Stop Smoking Cigarettes |
48; 45 | — |
| SECONDARY Use of Any Smoking Cessation Medication |
25; 14 | — |
Summary
The purpose of this study is to evaluate the use of "sampling" of smoking cessation medications (nicotine patches and lozenges) among smokers seen in primary care settings. Half of study participants will be provided with samples of medication, to use however they wish; the other half will not be provided with these samples. All smokers will be advised to quit through routine contact with their physician. After the primary care contact, all participants will be contacted by phone for three brief follow-up interviews, which will involve answering questionnaires about their smoking habits.
Eligibility Criteria
Inclusion Criteria
- age >=18
- daily (25+ days within past 30) cigarette smoker of >5 cigs/day
- English speaking
- recruited through primary care sites aligned with study
Exclusion Criteria
- no FDA contraindications for use of NRT:
- not pregnant, breastfeeding, or planning to become pregnant
- no recent (past 3 months) cardiovascular trauma: MI, stroke
Data sourced from ClinicalTrials.gov (NCT02096029). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.